515 related articles for article (PubMed ID: 25690491)
1. Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.
Eckman MH; Wise RE; Naylor K; Arduser L; Lip GY; Kissela B; Flaherty M; Kleindorfer D; Khan F; Schauer DP; Kues J; Costea A
Curr Med Res Opin; 2015 Apr; 31(4):603-14. PubMed ID: 25690491
[TBL] [Abstract][Full Text] [Related]
2. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
[TBL] [Abstract][Full Text] [Related]
3. Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.
Kunneman M; Branda ME; Noseworthy PA; Linzer M; Burnett B; Dick S; Spencer-Bonilla G; Fernandez CA; Gorr H; Wambua M; Keune S; Zeballos-Palacios C; Hargraves I; Shah ND; Montori VM
Trials; 2017 Sep; 18(1):443. PubMed ID: 28962662
[TBL] [Abstract][Full Text] [Related]
4. Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
Noseworthy PA; Yao X; Gersh BJ; Hargraves I; Shah ND; Montori VM
Int J Cardiol; 2017 Oct; 245():174-177. PubMed ID: 28733071
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.
Casciano JP; Singer DE; Kwong WJ; Fox ES; Martin BC
Am J Cardiovasc Drugs; 2012 Oct; 12(5):313-23. PubMed ID: 22920047
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Web-based education resources informing patients about stroke prevention in atrial fibrillation.
Pandya E; Bajorek BV
J Clin Pharm Ther; 2016 Dec; 41(6):667-676. PubMed ID: 27704588
[TBL] [Abstract][Full Text] [Related]
7. Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation.
Thomson R; Robinson A; Greenaway J; Lowe P;
Qual Saf Health Care; 2002 Mar; 11(1):25-31. PubMed ID: 12078365
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Appropriateness of Oral Anticoagulation for Atrial Fibrillation in Advanced Frailty: Use of Stroke and Bleeding Risk-Prediction Models.
O'Caoimh R; Igras E; Ramesh A; Power B; O'Connor K; Liston R
J Frailty Aging; 2017; 6(1):46-52. PubMed ID: 28244558
[TBL] [Abstract][Full Text] [Related]
9. Balancing the risks of stroke and upper gastrointestinal tract bleeding in older patients with atrial fibrillation.
Man-Son-Hing M; Laupacis A
Arch Intern Med; 2002 Mar; 162(5):541-50. PubMed ID: 11871922
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Effect of a Patient Decision Aid for Atrial Fibrillation Stroke Prevention Therapy.
Loewen PS; Bansback N; Hicklin J; Andrade JG; Kapanen AI; Kwan L; Lynd LD; McClean A; MacGillivray J; Salmasi S
Ann Pharmacother; 2019 Jul; 53(7):665-674. PubMed ID: 30724102
[TBL] [Abstract][Full Text] [Related]
11. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HAS-BLED and HAS-BED Versus CHADS
Poli D; Antonucci E; Pengo V; Testa S; Palareti G
Am J Cardiol; 2017 Apr; 119(7):1012-1016. PubMed ID: 28237286
[TBL] [Abstract][Full Text] [Related]
13. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation.
Garcia DA
Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997
[TBL] [Abstract][Full Text] [Related]
14. Visual Aid Tool to Improve Decision Making in Anticoagulation for Stroke Prevention.
Saposnik G; Joundi RA
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2380-5. PubMed ID: 27318647
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and usability of a mobile health tool on anticoagulation management for patients with atrial fibrillation: a pilot study.
Zhang C; Pan MM; Wang N; Wang WW; Li Z; Gu ZC; Lin HW
Eur J Clin Pharmacol; 2022 Feb; 78(2):293-304. PubMed ID: 34671819
[TBL] [Abstract][Full Text] [Related]
16. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
17. How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?
Quinn GR; Singer DE; Chang Y; Go AS; Borowsky LH; Fang MC
Am J Cardiol; 2016 Sep; 118(5):697-9. PubMed ID: 27394408
[TBL] [Abstract][Full Text] [Related]
18. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
Palamaner Subash Shantha G; Bhave PD; Girotra S; Hodgson-Zingman D; Mazur A; Giudici M; Chrischilles E; Vaughan Sarrazin MS
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28408716
[TBL] [Abstract][Full Text] [Related]
19. Personalizing Bridging Anticoagulation in Patients with Nonvalvular Atrial Fibrillation-a Microsimulation Analysis.
Pappas MA; Barnes GD; Vijan S
J Gen Intern Med; 2017 Apr; 32(4):464-470. PubMed ID: 28120297
[TBL] [Abstract][Full Text] [Related]
20. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
